Company overview
Arcinova is a Contract Research and Development Organisation (CRDO), providing a comprehensive range of integrated specialist services, spearheading the use of new technology processes to support the development of pioneering drugs for the treatment of life-threatening illnesses.
Website
arcinova.ukThis is an exciting time for Arcinova. We have a fantastic team, a world-class facility and strong market opportunity. We selected BGF because of its long-term approach to investing, and its ability to provide additional funding as we embark on a period of capital expenditure and international expansion.
Professor Ian Shott, executive chairCompany information
Head office
- Alnwick, Northumberland
CEO
- Professor Ian Shott
Chair
BGF office
BGF team
Investment date
- Jun 2018 - Feb 2021
Total BGF investment
- £5 million